Cefradine
From Wikipedia, the free encyclopedia
|
Cefradine
|
|
| Systematic (IUPAC) name | |
| (6R,7R)-7-{[(2R)-2-amino-2-(1-cyclohexa-1,4- dienyl)acetyl]amino}-3-methyl-8-oxo-5-thia- 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
|
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| Chemical data | |
| Formula | C16H19N3O4S |
| Mol. mass | 349.406 g/mol |
| Pharmacokinetic data | |
| Bioavailability | Well absorbed |
| Protein binding | <10% |
| Metabolism | Nil |
| Half life | 0.9 hours |
| Excretion | Renal, unchanged |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
℞ Prescription only |
| Routes | Oral, IM, IV |
Cefradine (INN) or cephradine (former BAN) is a first generation cephalosporin antibiotic.
Contents |
[edit] Indications
It has similar spectrum of activity to cefalexin.
[edit] Dosage
Dosage by mouth for adults is 250–500 mg every 6 hours, or 500 mg to 1 g every 12 hours. In severe infections up to 1 g every 6 hours may be used. Dosages for children are based upon their weight with 25–50 mg/kg total daily dose given in 2–4 divided doses.
[edit] Formulations
Capsules containing 250 mg or 500 mg, Syrup containing 250 mg/5 ml, or vials for injection containing 500 mg or 1 g.
[edit] References
- British National Formulary 45 March 2003
|
||||||||||||||||||||

